FDA Warning Letter — Gadal Laboratories Inc.

Case 655929 — FEI 3008611487

The FDA took a Warning Letter action against Gadal Laboratories Inc. on August 15, 2023 (Miami, FL). The action was issued by CDER and concerns drugs products. This facility has 4 recent FDA inspections on record.

Action Details

Facility
Gadal Laboratories Inc.
Date
August 15, 2023
Fiscal Year
2023
Product Type
Drugs
Center
CDER
Location
Miami, FL (United States)